HCA Healthcare, Inc. HCA
HCA Healthcare, Inc. (HCA) earns a Piotroski F-score of 6/9 (mixed financial health). It pays a dividend yielding 0.78% (safety: safe). FY2025 revenue was $75.6B at a 9.0% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Analyst price target
Recent analyst actions
| Date | Firm | Rating |
|---|---|---|
| 2026-08-03 | Wells Fargo | Equal-Weight (main) |
| 2026-07-28 | Goldman Sachs | Buy (main) |
| 2026-07-28 | Mizuho | Outperform (main) |
| 2026-07-27 | UBS | Buy (main) |
| 2026-07-27 | Morgan Stanley | Underweight (main) |
| 2026-07-27 | RBC Capital | Outperform (reit) |
Wall Street analyst consensus — a sentiment gauge, not our scoring.
Forward estimates · earnings calendar →
Consensus analyst estimates and scheduled dates — forward-looking, may change.
Smart money · insiders, last 12 months
Open-market insider purchases minus sells (SEC Form 4) — real buying with their own money is a bullish “smart money” signal; grants and option exercises are excluded.
How it ranks in Services · percentile among 982 companies
Percentile vs other Services companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 6/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Sector peers · similar-size Services companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| HCA | HCA Healthcare, Inc. | 6/9 | — | 12.8 | +7.1% |
| THC | TENET HEALTHCARE CORP | 3/9 | 2.33 | — | +3.1% |
| UHS | UNIVERSAL HEALTH SERVICES INC | 7/9 | 3.55 | 5.9 | +9.7% |
| CYH | COMMUNITY HEALTH SYSTEMS INC | 8/9 | 0.28 | 0.9 | -1.2% |
| ARDT | Ardent Health, Inc. | 5/9 | — | 10.3 | +6% |
| SGRY | Surgery Partners, Inc. | 5/9 | 1.09 | — | +6.2% |
| GOOG | Alphabet Inc. | 5/9 | 6.79 | 31.1 | +15.1% |
About HCA Healthcare, Inc.
HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States. The company owns, manages, and operates hospitals, ASCs, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, as well as rehabilitation and physical therapy centers, physician practices, home health agencies, hospices, outpatient physical therapy providers, home and community-based services providers, and various other facilities. Its general and acute care hospitals offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic services, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
FAQ
Is HCA financially healthy?
HCA Healthcare, Inc.'s Piotroski F-score is 6/9 (8–9 is excellent, 0–3 weak).
Does HCA pay a dividend, and is it safe?
Yes. HCA Healthcare, Inc. pays a dividend yielding about 0.78% with a 10.0% payout ratio, rated “safe” for safety.
How profitable is HCA?
In FY2025, HCA Healthcare, Inc. had a net margin of 9.0%.
Is HCA overvalued or undervalued?
HCA Healthcare, Inc. trades at about 14.6× trailing earnings — near its 10-year norm (10-year range 11.0×–17.2×, median 14.9×). Stocktoria reports the data, not buy/sell advice.
What is the analyst price target for HCA?
The average Wall-Street price target for HCA Healthcare, Inc. is $454.57, about 9.6% above the recent price, from 21 analysts (consensus: buy).
Is HCA a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on HCA Healthcare, Inc.: a Piotroski F-score of 6/9, a P/E of about 12.8×, a dividend yield of 0.78%. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.